Novartis and Pfizer Join Forces to Treat Nonalcoholic Steatohepatitis
According to a story from globenewswire.com, the drug developers Pfizer and Novartis have recently announced the beginning of a collaborative effort to test new potential therapies for nonalcoholic steatohepatitis (NASH).…